Venkat Pharma Ltd
Venkat Pharma Ltd is engaged in the manufacture and sale of finished dosages of pharmaceutical products in India.
- Market Cap ₹ Cr.
- Current Price ₹ 3.40
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 10.0
- Dividend Yield 0.00 %
- ROCE -0.30 %
- ROE %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.34 times its book value
Cons
- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Jun 2006 15m | Mar 2007 9m | Mar 2008 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 13.84 | 0.63 | 1.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 12.56 | 6.92 | 2.39 | 0.20 | 0.04 | 0.02 | 0.03 | 0.02 | |
| Operating Profit | 1.28 | -6.29 | -1.34 | -0.20 | -0.04 | -0.02 | -0.03 | -0.02 |
| OPM % | 9.25% | -998.41% | -127.62% | |||||
| 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest | 2.03 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.28 | 0.13 | 0.06 | 0.04 | 0.02 | 0.02 | 0.02 | 0.00 |
| Profit before tax | -1.03 | -6.67 | -1.39 | -0.24 | -0.06 | -0.04 | -0.05 | -0.02 |
| Tax % | -5.83% | 0.15% | 0.00% | 4.17% | 0.00% | 0.00% | 0.00% | |
| -0.97 | -6.68 | -1.39 | -0.25 | -0.06 | -0.04 | -0.04 | -0.02 | |
| EPS in Rs | -1.94 | -13.39 | -2.79 | -0.50 | -0.12 | -0.08 | -0.08 | -0.04 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 23% |
| TTM: | 33% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Jun 2006 | Mar 2007 | Mar 2008 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 |
| Reserves | 1.40 | -5.28 | -6.67 | -7.38 | -7.44 | -7.48 | -7.53 |
| 15.63 | 16.20 | 16.19 | 16.19 | 16.19 | 19.20 | 19.22 | |
| 7.66 | 4.48 | 4.67 | 4.47 | 4.39 | 1.42 | 1.31 | |
| Total Liabilities | 29.68 | 20.39 | 19.18 | 18.27 | 18.13 | 18.13 | 17.99 |
| 1.21 | 1.08 | 1.00 | 0.92 | 0.89 | 0.87 | 0.85 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 28.47 | 19.31 | 18.18 | 17.35 | 17.24 | 17.26 | 17.14 | |
| Total Assets | 29.68 | 20.39 | 19.18 | 18.27 | 18.13 | 18.13 | 17.99 |
Cash Flows
Figures in Rs. Crores
| Jun 2006 | Mar 2007 | Mar 2008 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | |
|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | -0.01 | 0.00 | ||||
| 0.00 | 0.00 | 0.00 | 0.00 | ||||
| 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Net Cash Flow | 0.00 | 0.00 | -0.01 | 0.00 | |||
| Free Cash Flow | 0.00 | 0.00 | -0.01 | 0.00 | |||
| CFO/OP | 0% | 0% | 50% | 0% |
Ratios
Figures in Rs. Crores
| Jun 2006 | Mar 2007 | Mar 2008 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 482.89 | 8,632.54 | 4,599.00 | ||||
| Inventory Days | 181.06 | 394.02 | 890.44 | ||||
| Days Payable | 182.29 | 652.11 | 1,776.87 | ||||
| Cash Conversion Cycle | 481.65 | 8,374.44 | 3,712.57 | ||||
| Working Capital Days | 539.59 | 8,487.70 | 4,672.00 | ||||
| ROCE % | -9.14% | -0.44% | -0.26% | -0.30% |
Documents
Announcements
No data available.
Annual reports
No data available.